Revvity | PKI - Debt



Revvity reported $3.17B in Debt for its fiscal quarter ending in March of 2025.


Debt Change Date
Adcock Ingram Holdings ZAR 969.4M 688.86M Dec/2024
Agilent USD 3.41B 86M Jul/2025
Align Technology USD 118.54M 118.54M Mar/2025
Bio Techne USD 346M 16M Jun/2025
Bio-Rad Laboratories USD 1.41B 204.6M Jun/2025
Bruker USD 2.44B 321.5M Jun/2025
Celltrion KRW 2.22T 24.87B Mar/2025
Charles River Laboratories USD 2.79B 275.28M Jun/2025
Cspc Pharmaceutical CNY 507.33M 118.46M Dec/2024
Danaher USD 17.36B 878M Jun/2025
Dentsply International USD 2.49B 159M Jun/2025
Dianthus Therapeutics USD 1.33M 161K Jun/2025
Divis Laboratories Ltd 40M 40M Mar/2025
Edwards Lifesciences USD 699.4M 101.7M Mar/2025
Exact Sciences USD 2.32B 16.28M Jun/2025
Hologic USD 2.52B 8.5M Jun/2025
Illumina USD 2.6B 608M Jun/2025
Intuitive Surgical USD 0 0 Mar/2025
IQVIA Holdings USD 15.49B 1.16B Jun/2025
Kangmei Pharma CNY 221.82M 958.68M Mar/2025
Knight Therapeutics CAD 58.22M 109K Sep/2024
Laboratorios Farma EUR 129.3M 14.89M Jun/2025
Laboratory Of America USD 6.52B 107.7M Mar/2025
Malin Corporation EUR 0 0 Dec/2024
Medical Developments International AUD 2.14M 144K Dec/2024
Mettler Toledo International USD 2.18B 109.83M Jun/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
Neuren Pharmaceuticals AUD 0 0 Dec/2024
Organigram Holdings CAD 9.15M 35.6M Jun/2025
Pharma Mar EUR 51.4M 405K Jun/2025
Qiagen NV USD 1.44B 35.7M Jun/2025
Quest Diagnostics USD 6.38B 525M Jun/2025
Quidel USD 2.79B 293M Jun/2025
Repligen USD 533.72M 149.97M Jun/2025
Revvity USD 3.17B 17.91M Mar/2025
Sartorius EUR 4.66B 25.7M Jun/2025
Sino Biopharmaceutical CNY 9.71B 33.98M Dec/2024
Thermo Fisher Scientific USD 34.19B 2.91B Mar/2025
Tilray USD 351.72M 15.26M Nov/2024
Waters USD 1.54B 81.64M Jun/2025
Zz Pientze Pharmaceu 1.12B 70.31M Mar/2025